Average Co-Inventor Count = 3.33
ph-index = 37
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Isis Pharmaceuticals, Inc. (109 from 1,035 patents)
2. Ionis Pharmaceuticals, Inc. (77 from 270 patents)
3. Biogen Ma Inc. (6 from 245 patents)
4. Regulus Therapeutics Inc. (4 from 61 patents)
5. Lonis Pharmaceuticals, Inc. (4 from 5 patents)
6. Eli Lilly and Company (3 from 4,419 patents)
7. Alnylam Pharmaceuticals, Inc. (2 from 436 patents)
8. University of Texas System (1 from 5,386 patents)
9. University of British Columbia (1 from 922 patents)
10. Alaylam Pharmacueuticals, Inc. (1 from 1 patent)
201 patents:
1. 12291709 - Compositions and methods for modulating apolipoprotein (a) expression
2. 12234447 - Modified compounds and uses thereof
3. 12215321 - Modulators of diacyglycerol acyltransferase 2 (DGAT2)
4. 12152244 - Selective antisense compounds and uses thereof
5. 12110491 - Selective reduction of allelic variants
6. 12091662 - Compositions for modulating tau expression
7. 11959080 - Methods and compositions for inhibiting PMP22 expression
8. 11851655 - Compositions and methods for modulating apolipoprotein (a) expression
9. 11732265 - Compositions and methods for modulating complement factor B expression
10. 11732261 - Selective antisense compounds and uses thereof
11. 11633483 - Modulators of PCSK9 expression
12. 11613752 - Compositions and methods for modulating PKK expression
13. 11591595 - Compositions for modulating Tau expression
14. 11566245 - Oligomeric compounds comprising bicyclic nucleotides and uses thereof
15. 11492615 - Antisense compounds and uses thereof